MENU
UTHR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

United Therapeutics (UTHR) Earnings Date & Reports

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more

A.I. Advisor
published Earnings

UTHR is expected to report earnings to $7.13 per share on February 25

United Therapeutics UTHR Stock Earnings Reports
Q4'25
Est.
$7.13
Q3'25
Missed
by $0.16
Q2'25
Missed
by $0.94
Q1'25
Beat
by $0.10
Q4'24
Missed
by $0.49
The last earnings report on October 29 showed earnings per share of $7.16, missing the estimate of $7.32. With 61.92K shares outstanding, the current market capitalization sits at 19.91B.
View a ticker or compare two or three
UTHR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. UTHR showed earnings on October 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com